ACCESSION: MSBNK-SMB_Measured-HSA001P0158001
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.03.04 (Averaged 2025.02.14, Processed 2025.02.14, Annotated 2025.02.21, Curated 2025.03.04)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 49
COMMENT: RAW_SPEC {'BLK02_3662': {'bp': 243179.0, 'sum': 1026127.0}, 'ProcedureBlank_3704': {'bp': 237753.0, 'sum': 998101.0}, 'BLK01_3619': {'bp': 235629.0, 'sum': 1107289.0}, '19_posi_3840': {'bp': 226808.0, 'sum': 918360.0}, '1_posi_3601': {'bp': 226795.0, 'sum': 961671.0}, '5_posi_3660': {'bp': 223589.0, 'sum': 946634.0}, '1_posi_3662': {'bp': 219630.0, 'sum': 940393.0}, '2_posi_3681': {'bp': 219184.0, 'sum': 934632.0}, 'ProcedureBlank_3640': {'bp': 218159.0, 'sum': 975168.0}, '14_posi_3758': {'bp': 216637.0, 'sum': 916839.0}, '12_posi_3702': {'bp': 215544.0, 'sum': 939203.0}, 'BLK02_3797': {'bp': 213422.0, 'sum': 923155.0}, '11_posi_3684': {'bp': 211870.0, 'sum': 896724.0}, '8_posi_3705': {'bp': 211274.0, 'sum': 905468.0}, '14_posi_3685': {'bp': 210630.0, 'sum': 875246.0}, '3_posi_3683': {'bp': 210224.0, 'sum': 865789.0}, '4_posi_3758': {'bp': 210095.0, 'sum': 896097.0}, '4_posi_3682': {'bp': 207566.0, 'sum': 866611.0}, '11_posi_3621': {'bp': 207505.0, 'sum': 887044.0}, '2_posi_3619': {'bp': 205823.0, 'sum': 889168.0}, 'ProcedureBlank_3779': {'bp': 204379.0, 'sum': 896315.0}, '4_posi_3619': {'bp': 203629.0, 'sum': 938595.0}, '9_posi_3685': {'bp': 203435.0, 'sum': 844041.0}, '13_posi_3681': {'bp': 199646.0, 'sum': 807352.0}, '9_posi_3755': {'bp': 195301.0, 'sum': 827766.0}, '15_posi_3684': {'bp': 194938.0, 'sum': 858094.0}, '16_posi_3686': {'bp': 194639.0, 'sum': 837486.0}, '7_posi_3702': {'bp': 193233.0, 'sum': 813994.0}, '19_posi_3751': {'bp': 190966.0, 'sum': 799837.0}, '5_posi_3778': {'bp': 190889.0, 'sum': 845914.0}, '10_posi_3735': {'bp': 189807.0, 'sum': 879738.0}, '18_posi_3747': {'bp': 188749.0, 'sum': 835212.0}, '18_posi_3821': {'bp': 188434.0, 'sum': 835772.0}, '16_posi_3757': {'bp': 187921.0, 'sum': 837917.0}, '12_posi_3639': {'bp': 183123.0, 'sum': 882569.0}, '4_posi_3558': {'bp': 183096.0, 'sum': 860876.0}, '13_posi_3618': {'bp': 180281.0, 'sum': 854863.0}, '7_posi_3639': {'bp': 179898.0, 'sum': 795342.0}, '16_posi_3620': {'bp': 179552.0, 'sum': 815685.0}, '8_posi_3800': {'bp': 178663.0, 'sum': 844965.0}, '7_posi_3575': {'bp': 177767.0, 'sum': 799585.0}, '18_posi_3684': {'bp': 176407.0, 'sum': 791314.0}, '10_posi_3598': {'bp': 175632.0, 'sum': 867871.0}, '13_posi_3779': {'bp': 171658.0, 'sum': 822579.0}, '14_posi_3622': {'bp': 169638.0, 'sum': 817577.0}, '16_posi_3557': {'bp': 156698.0, 'sum': 816742.0}, '12_posi_3576': {'bp': 155739.0, 'sum': 763302.0}, '14_posi_3558': {'bp': 154411.0, 'sum': 761573.0}, '19_posi_3686': {'bp': 146563.0, 'sum': 715552.0}}
COMMENT: RETENTION_TIME_STDEV 0.145
COMMENT: PRECURSOR_M/Z_RAW 158.128540
COMMENT: PRECURSOR_M/Z_STDEV 0.000079
COMMENT: PRECURSOR_IN_MS1 mz 158.128878; int 41.013; delta(ppm) 1.456983
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+CH3OH+H; M+ACN+H; mz 167.129111; int 39.206; cor 0.687
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.573; C7H15N3O; [M+H]+; delta(ppm) 0.572805
COMMENT: PROPOSED_MF SevenGoldenRules 0.735; C6H11N3; [M+CH3OH+H]+; delta(ppm) 0.735439
COMMENT: PROPOSED_MF MS-FINDER 3.036; C6H11N3; [M+CH3OH+H]+; delta(ppm) 0.565649
COMMENT: PROPOSED_MF MS-FINDER 2.813; C7H15N3O; [M+H]+; delta(ppm) 0.565649
COMMENT: PROPOSED_MF SIRIUS5_Sirius 25.927; C7H15N3O; [M+H]+; delta(ppm) 0.565649
COMMENT: PROPOSED_MF SIRIUS5_Sirius 14.226; C6H11N3; [M+CH4O+H]+; delta(ppm) 0.565649
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C7H15N3O; [M+H]+; delta(ppm) 0.565649
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C6H11N3; [M+CH4O+H]+; delta(ppm) 0.565649
COMMENT: PROPOSED_MF SIRIUS6_Sirius 37.434; C7H15N3O; [M+H]+; delta(ppm) 0.565649
COMMENT: PROPOSED_MF SIRIUS6_Sirius 37.434; C6H11N3; [M+CH4O+H]+; delta(ppm) 0.565649
COMMENT: PROPOSED_MF SIRIUS6_Sirius 13.674; C5H13N6; [M+H]+; delta(ppm) 9.056676
COMMENT: PROPOSED_MF SIRIUS6_Sirius 6.221; C9H17O2; [M+H]+; delta(ppm) -7.925233
COMMENT: PROPOSED_MF SIRIUS6_Sirius 6.221; C8H13O; [M+CH4O+H]+; delta(ppm) -7.925233
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C7H15N3O; [M+H]+; delta(ppm) 0.565649
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C6H11N3; [M+CH4O+H]+; delta(ppm) 0.565649
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.205; NKNWKZRTEZPNSM-UHFFFAOYSA-N; [M+H]+; O=C(N)NN=CC(CC)CC
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.171; FHQDWPCFSJMNCT-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-Methylhistamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.859; CPAGZVLINCPJEH-UHFFFAOYSA-N; [M+CH3OH+H]+; 3-Methylhistamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.668; PHSPJQZRQAJPPF-UHFFFAOYSA-N; [M+CH3OH+H]+; N-Methylhistamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.668; KDHWOCLBMVSZPG-UHFFFAOYSA-N; [M+CH3OH+H]+; 1H-imidazole-1-propylamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.628; UGYXPZQILZRKJJ-UHFFFAOYSA-N; [M+CH3OH+H]+; 4-methylhistamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.628; XDKYTXBAVJELDQ-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-methylhistamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.628; XNQIOISZPFVUFG-RXMQYKEDSA-N; [M+CH3OH+H]+; (R)-alpha-methylhistamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.546; LNWMKFPGICKEQH-UHFFFAOYSA-N; [M+CH3OH+H]+; (1-methyl-2,3-dihydropyridin-6-ylidene)hydrazine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.444; NKNWKZRTEZPNSM-UHFFFAOYSA-N; [M+H]+; [(2-ethylbutylidene)amino]urea
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; NKNWKZRTEZPNSM-UHFFFAOYSA-N; [M+H]+; [(2-ethylbutylidene)amino]urea
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; KDHWOCLBMVSZPG-UHFFFAOYSA-N; [M+CH3OH+H]+; 1H-imidazole-1-propylamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.943; XDKYTXBAVJELDQ-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-methylhistamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.925; UGYXPZQILZRKJJ-UHFFFAOYSA-N; [M+CH3OH+H]+; 4-methylhistamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.903; FHQDWPCFSJMNCT-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-Methylhistamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.903; CPAGZVLINCPJEH-UHFFFAOYSA-N; [M+CH3OH+H]+; 3-Methylhistamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.877; PHSPJQZRQAJPPF-UHFFFAOYSA-N; [M+CH3OH+H]+; N-Methylhistamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.872; XNQIOISZPFVUFG-RXMQYKEDSA-N; [M+CH3OH+H]+; (R)-alpha-methylhistamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.646; LNWMKFPGICKEQH-UHFFFAOYSA-N; [M+CH3OH+H]+; (1-methyl-2,3-dihydropyridin-6-ylidene)hydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.686; XMFYMWXCIWIHAC-UHFFFAOYSA-N; [M+H]+; N,N-dimethylpiperazine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.735; FWHRLKTXFMRLDV-UHFFFAOYSA-N; [M+H]+; 4-(methylamino)piperidine-4-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.629; VRZZMRYGHFNKEN-UHFFFAOYSA-N; [M+H]+; 2-(4-methylpiperazin-1-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.493; SOTHHBNFPDRYCM-UHFFFAOYSA-N; [M+H]+; N-methyl-2-piperazin-1-ylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.490; XNQIOISZPFVUFG-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-(1H-imidazol-5-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.410; FWFVZEXRAAFFEU-UHFFFAOYSA-N; [M+H]+; N'-hydroxy-2-piperidin-1-ylethanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.297; FHQDWPCFSJMNCT-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(1-methylimidazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.215; HQXKCSSNQJUVML-UHFFFAOYSA-N; [M+H]+; 1-(3-aminopropyl)-1,3-diazinan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.142; VVWMANLRLRFZIZ-UHFFFAOYSA-N; [M+H]+; 3-piperazin-1-ylpropanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.103; DIDCDJTVKPODTM-UHFFFAOYSA-N; [M+H]+; N-ethylpiperazine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.062; KDHWOCLBMVSZPG-UHFFFAOYSA-N; [M+CH3OH+H]+; 3-imidazol-1-ylpropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.062; WKRXPJVFLDWSFL-UHFFFAOYSA-N; [M+H]+; 4-ethylpiperazine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.062; JWRVCVWALQWYIJ-UHFFFAOYSA-N; [M+H]+; 2-(4-aminopiperidin-1-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.050; ANHJTNKMQWWMDJ-UHFFFAOYSA-N; [M+H]+; 2-amino-1-(4-methylpiperazin-1-yl)ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.043; NGWNLUZOEYRHAX-UHFFFAOYSA-N; [M+H]+; 1-methyl-3-piperidin-4-ylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.014; VEEWCGJMSJUBTC-UHFFFAOYSA-N; [M+H]+; N'-hydroxy-1-methylpiperidine-4-carboximidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.013; ASTGCFFFALEDKG-UHFFFAOYSA-N; [M+H]+; N'-hydroxy-1-methylpiperidine-3-carboximidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.012; DXLMAWKTIWMTIM-UHFFFAOYSA-N; [M+H]+; 2-piperazin-1-ylpropanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.011; TUDVAMWISALGGV-UHFFFAOYSA-N; [M+H]+; 2-(1,4-diazepan-1-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.989; SCLKLJIOJCJNNM-UHFFFAOYSA-N; [M+H]+; 4-amino-N-methylpiperidine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.989; YXJSNYWHCBOJHS-UHFFFAOYSA-N; [M+H]+; 2-(3-aminopiperidin-1-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.986; YRKJGBJXQSEVRL-UHFFFAOYSA-N; [M+H]+; 1-methyl-3-(pyrrolidin-2-ylmethyl)urea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.935; PQJWLDHHBMBKDM-JTHIGBGISA-N; [M+H]+; (2E)-2-hydroxyimino-N,N-dimethyl-N'-propylethanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.920; PBEHKSXYRLKENN-UHFFFAOYSA-N; [M+H]+; 1-[3-(methylamino)propyl]imidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.903; RPOOCEPQRXHAMR-UHFFFAOYSA-N; [M+H]+; (1-ethylpyrrolidin-3-yl)urea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.893; FDPBEKRDJYDLHO-UHFFFAOYSA-N; [M+H]+; azepan-4-ylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.892; DTZYYZWYSRPUGM-UHFFFAOYSA-N; [M+H]+; piperidin-4-ylmethylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.875; PHSPJQZRQAJPPF-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(1H-imidazol-5-yl)-N-methylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.837; UJCRXTPCKWHFIK-LURJTMIESA-N; [M+H]+; (3S)-3-amino-N-ethylpyrrolidine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.821; ZOMKCDYJHAQMCU-UHFFFAOYSA-N; [M+CH3OH+H]+; 4-butyl-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.820; MVWYSRAIAUAMJL-UHFFFAOYSA-N; [M+H]+; N,N-dimethylpiperazine-2-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.817; WXEPBEURAILKFS-UHFFFAOYSA-N; [M+H]+; 4-(2-aminoethyl)-1-methylpiperazin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.808; DGBWASUSQBEAOY-UHFFFAOYSA-N; [M+H]+; 2-methyl-1-(oxolan-3-ylmethyl)guanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.794; PSTIPACOMKTMDU-UHFFFAOYSA-N; [M+H]+; 3-methyl-5-pyrrolidin-3-yl-1,2,4-oxadiazolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.765; VZVGVHNZWUQMRZ-UHFFFAOYSA-N; [M+H]+; 1-amino-3-cyclohexylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.737; KIPRVSOTALWIDV-UHFFFAOYSA-N; [M+H]+; 3-amino-1-piperazin-1-ylpropan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.706; WAKDYASVWVWGLD-UHFFFAOYSA-N; [M+H]+; 3-amino-N,N-dimethylpyrrolidine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.682; HOXAJWHRILSLKM-UHFFFAOYSA-N; [M+H]+; (4-methylpentan-2-ylideneamino)urea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.464; OUKAZIMLLPOLKQ-UHFFFAOYSA-N; [M+H]+; 4-methoxypiperidine-1-carboximidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.383; UGYXPZQILZRKJJ-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(5-methyl-1H-imidazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.180; TVKAZNBVXZKTAV-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-piperazin-2-ylacetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.120; MECWXEINLHIGIW-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-propan-2-ylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.101; CWQHAFKSCIBIDU-UHFFFAOYSA-N; [M+CH3OH+H]+; 4-methylpiperazine-2-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.100; UVVVPHSDEZUWCT-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-methylpiperazine-2-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.099; LONOODCVABUHFO-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-propylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.096; CPAGZVLINCPJEH-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(3-methylimidazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.046; HQNOODJDSFSURF-UHFFFAOYSA-N; [M+CH3OH+H]+; 3-(1H-imidazol-2-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.032; XHOHVIKZCDXJNK-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-piperazin-1-ylacetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.009; XDKYTXBAVJELDQ-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(2-methyl-1H-imidazol-5-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.965; MAGGRXZKFUAOGD-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-ethyl-5-methylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.959; SNRYBQUHJRIMJO-UHFFFAOYSA-N; [M+CH3OH+H]+; 5-propyl-1H-pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.954; YOQGVTQBADVJTC-UHFFFAOYSA-N; [M+CH3OH+H]+; 4-ethyl-5-methyl-1H-pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.952; IPMYPLFTEUENGG-UHFFFAOYSA-N; [M+CH3OH+H]+; 5-ethyl-1-methylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.949; KPWCURLGTSCHNE-UHFFFAOYSA-N; [M+CH3OH+H]+; 5-ethyl-4-methyl-1H-pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.944; UQTLFNBARWAWIS-UHFFFAOYSA-N; [M+CH3OH+H]+; 4-propan-2-yl-1H-pyrazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.931; BDOQDYNVOVZWSL-UHFFFAOYSA-N; [M+CH3OH+H]+; 4-ethyl-5-methyl-1H-imidazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.920; INSBBZDRQQVATI-UHFFFAOYSA-N; [M+CH3OH+H]+; 5-propan-2-yl-1H-pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.919; UWVUXGHAXNILPG-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-pyrazol-1-ylpropan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.913; CUZNBROTVLFZKQ-UHFFFAOYSA-N; [M+CH3OH+H]+; N-methyl-2-pyrazol-1-ylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.884; QKVROWZQJVDFSO-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(2-methylimidazol-1-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.874; OEXNVHXUPNHOPP-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-propan-2-ylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.862; XHWLCRAUUAFQTD-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-ethyl-4-methylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.845; NEEHZOMPACKFRR-UHFFFAOYSA-N; [M+CH3OH+H]+; 4-methyl-3-propan-2-yl-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.845; YMMVIBHFGRZKPK-UHFFFAOYSA-N; [M+CH3OH+H]+; (1,5-dimethylpyrazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.844; DMDDBNVQWLCYMJ-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-propylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.840; LEHGOSZFUSOULZ-UHFFFAOYSA-N; [M+CH3OH+H]+; N-methyl-1-(1-methylpyrazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.835; JSXVMXHCFBPCLV-UHFFFAOYSA-N; [M+CH3OH+H]+; 3-pyrazol-1-ylpropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.835; MIAQYVFWXDEYAK-UHFFFAOYSA-N; [M+CH3OH+H]+; (1-ethylpyrazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.832; VVIZVEAXGCWHOM-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(1-methylpyrazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.830; ZRRJOIZUONRZAO-UHFFFAOYSA-N; [M+CH3OH+H]+; N,N-dimethyl-1-(1H-pyrazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.826; KIPVVJYELYMMQA-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-(1-methylpyrazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.823; CHGIPIYKGPNYKT-UHFFFAOYSA-N; [M+CH3OH+H]+; N-methyl-1-(2-methylpyrazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.822; PUVWFSUNHHFSFG-UHFFFAOYSA-N; [M+CH3OH+H]+; N-ethyl-1-methylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.820; SJAACDLJWHJJFO-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-(1H-imidazol-2-yl)-N,N-dimethylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.817; RRQYXOXCBVYWMU-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-(2-methylpyrazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.817; PWGUGJCHHQGZGX-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(5-methylpyrazol-1-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.817; VBRQKQJNZFDLDO-UHFFFAOYSA-N; [M+CH3OH+H]+; (2-ethylpyrazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.815; WVKQECDSKDGQDQ-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-butyltriazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.814; LTBJIMCRWXQMMM-UHFFFAOYSA-N; [M+CH3OH+H]+; 5-ethyl-1-methylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.813; XIIAZKSXQSTSEQ-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-ethyl-5-methylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.810; IHDFTEVCMVTMSP-UHFFFAOYSA-N; [M+CH3OH+H]+; 3-(1H-imidazol-5-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.808; UGBXFYZRZQPHFK-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(2-methylpyrazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.806; IHOYUFHPGKNPEJ-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-ethyl-N-methylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.804; YGAHXOAPDMHPMD-UHFFFAOYSA-N; [M+CH3OH+H]+; (2,3-dimethylimidazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.802; VWPUDWHRYBWJRG-UHFFFAOYSA-N; [M+CH3OH+H]+; N-methyl-1-(5-methyl-1H-imidazol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.800; YZCXLAHTHBVYGB-UHFFFAOYSA-N; [M+CH3OH+H]+; N-methyl-1-(3-methylimidazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.798; RSAZAAWMBSYBFM-UHFFFAOYSA-N; [M+CH3OH+H]+; N-methyl-1-(1-methylimidazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.793; LDDGBHZRCXCJMR-UHFFFAOYSA-N; [M+CH3OH+H]+; (5-ethyl-1H-imidazol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.789; YDCBPRUBLDZYBI-UHFFFAOYSA-N; [M+CH3OH+H]+; (2-ethyl-1H-imidazol-5-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.789; JMVGTUJLDTZQFC-UHFFFAOYSA-N; [M+CH3OH+H]+; (3-ethylimidazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.788; ZKVYCQSCJORSLS-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(1H-imidazol-2-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.788; XCKQBMQJPNDJLD-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(1-methylimidazol-2-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.786; BDBSRCUXKGLKOH-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(1H-imidazol-2-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.785; MIELZMJNYYRADO-UHFFFAOYSA-N; [M+CH3OH+H]+; 3-methyl-4-propyl-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.784; BJHXFXZRIMEDER-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-(1H-pyrazol-4-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.783; UUHRZOGUDROUKQ-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-imidazol-1-yl-N-methylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.781; XAKAVKFLXVMKJT-UHFFFAOYSA-N; [M+CH3OH+H]+; (1-ethylimidazol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.781; ICKXLSHRBIKQFM-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-(1-methylimidazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.780; ARKPMOZBRKFUHB-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-(3-methylimidazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.776; SKWZCBKDKBTIGK-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-propylimidazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.771; WTKBDVNJNVEEEN-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-propan-2-ylimidazol-4-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -127.080; JSXVMXHCFBPCLV; [M+CH4O+H]+; 3-pyrazolylpropylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -134.871; FHQDWPCFSJMNCT; [M+CH4O+H]+; Lopac-M-4910
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -136.870; ANHJTNKMQWWMDJ; [M+H]+; 2-amino-1-(4-methylpiperazin-1-yl)ethanone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -142.703; KDHWOCLBMVSZPG; [M+CH4O+H]+; QuadraPure&reg; IMDAZ
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -145.282; CPAGZVLINCPJEH; [M+CH4O+H]+; 3-Methylhistamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -146.323; QKVROWZQJVDFSO; [M+CH4O+H]+; ACMC-20dure
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -147.666; KIPRVSOTALWIDV; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -153.065; LLUVLTBWVXCDQN; [M+CH4O+H]+; (1-ethylpyrazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -154.919; ZOMKCDYJHAQMCU; [M+CH4O+H]+; Butrizol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -157.448; NCMDCWBSYIDNHM; [M+CH4O+H]+; 2-(4-methylpyrazolyl)ethylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -162.637; FWHRLKTXFMRLDV; [M+H]+; 4-(Methylamino)piperidine-4-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -166.437; CUZNBROTVLFZKQ; [M+CH4O+H]+; N-methyl-2-pyrazol-1-ylethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -167.105; MIAQYVFWXDEYAK; [M+CH4O+H]+; (1-ethylpyrazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -169.450; XDKYTXBAVJELDQ; [M+CH4O+H]+; 2-Methylhistamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -170.723; TZLVUWBGUNVFES; [M+CH4O+H]+; ethylmethylpyrazolamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -172.242; DSLSNSBQZMOQQK; [M+H]+; N-Amidinohexanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -173.165; XIIAZKSXQSTSEQ; [M+CH4O+H]+; 1-ethyl-5-methylpyrazole-4-ylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -174.594; DAOWQCXPMWGSBW; [M+CH4O+H]+; 5-aminomethyl-1,3-dimethylpyrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -175.027; RPOOCEPQRXHAMR; [M+H]+; (1-Ethyl-3-pyrrolidinyl)urea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -175.067; MAGGRXZKFUAOGD; [M+CH4O+H]+; 1-ethyl-5-methylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -175.835; JGYXJOBBROGMLL; [M+CH4O+H]+; (1,5-dimethylpyrazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -175.888; PUVWFSUNHHFSFG; [M+CH4O+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -178.344; AHRQLLLOCPXPCS; [M+CH4O+H]+; 2-isopropylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -179.300; IHDFTEVCMVTMSP; [M+CH4O+H]+; Homohistamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -179.585; MECWXEINLHIGIW; [M+CH4O+H]+; 1-isopropylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -180.734; QVNYNCBHNRXHTB; [M+CH4O+H]+; 3-ethyl-1-methyl-1H-pyrazol-5-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -182.275; IZJQTFALMLLZQJ; [M+CH4O+H]+; 1-(1-methylpyrazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -183.979; RRQYXOXCBVYWMU; [M+CH4O+H]+; 1-(1-methylpyrazol-5-yl)ethylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -187.776; BJOZTPFIJGKTJI; [M+CH4O+H]+; methyl[(1-methylpyrazol-3-yl)methyl]amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -190.982; CHGIPIYKGPNYKT; [M+CH4O+H]+; 1-methyl-5-[(methylamino)methyl]pyrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -191.981; XHWLCRAUUAFQTD; [M+CH4O+H]+; Ambcb4014354
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -192.001; PHSPJQZRQAJPPF; [M+CH4O+H]+; Tocris-0573
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -193.410; KNVTVOWFXJOWKI; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -193.808; SSDGMKHZMNTWLS; [M+CH4O+H]+; trimethylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -193.938; LEHGOSZFUSOULZ; [M+CH4O+H]+; N-Methyl-1-(1-methyl-1H-pyrazol-4-yl)
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -194.794; XMFYMWXCIWIHAC; [M+H]+; 1-(Dimethylcarbamoyl)piperazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -196.492; LWDYSDHYADWNAS; [M+H]+; AP-1,3-Dazaha
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -196.559; YFSZWZHEKIMAJJ; [M+CH4O+H]+; Ambcb4101396
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -204.059; NBWAZUNSLABYAM; [M+CH4O+H]+; 1-Aza-2,7-diiminocycloheptane
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -208.744; NKPUYKJNDVFPCP; [M+CH4O+H]+; 1H-Pyrazole-4-propanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -220.739; UGYXPZQILZRKJJ; [M+CH4O+H]+; 4-Methylhistamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -228.706; XNQIOISZPFVUFG; [M+CH4O+H]+; Tocris-0569
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -240.163; UQTLFNBARWAWIS; [M+CH4O+H]+; 4-isopropyl-1H-pyrazol-5-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -242.293; QBUQWOXNOUFIGB; [M+CH4O+H]+; (3-ethyl-1H-pyrazol-5-yl)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -246.970; MPIROZKBCRIFBH; [M+H]+; 1,2,6-Trimethyl-4-nitrosopiperazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -250.397; HOXAJWHRILSLKM; [M+H]+; 4-methyl-2-pentanone semicarbazone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -256.363; INSBBZDRQQVATI; [M+CH4O+H]+; 3-Isopropyl-1H-pyrazol-5-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.166; JSXVMXHCFBPCLV; [M+CH4O+H]+; 3-pyrazolylpropylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.103; ANHJTNKMQWWMDJ; [M+H]+; 2-amino-1-(4-methylpiperazin-1-yl)ethanone
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -107.472; HQNOODJDSFSURF; [M+CH4O+H]+; 3-(1H-Imidazol-2-YL)propan-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -126.051; VRZZMRYGHFNKEN; [M+H]+; 2-(4-Methylpiperazin-1-YL)acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -130.117; NBWAZUNSLABYAM; [M+CH4O+H]+; 2H-Azepin-7-amine, 3,4,5,6-tetrahydro-2-imino-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -131.932; XEVGYQRKMCBAGE; [M+CH4O+H]+; 3,4-dihydro-2H-pyridine-1-carboximidamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -137.734; XMFYMWXCIWIHAC; [M+H]+; [Hydroxy(piperazin-1-yl)methylidene]-dimethylazanium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -138.513; QKVROWZQJVDFSO; [M+CH4O+H]+; 2-(2-methyl-1H-imidazol-1-yl)ethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -144.262; CWQHAFKSCIBIDU; [M+CH4O+H]+; (2S)-4-methylpiperazine-2-carbonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -145.263; LNWMKFPGICKEQH; [M+CH4O+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -147.818; ZOMKCDYJHAQMCU; [M+CH4O+H]+; 4-butyl-1H-1,2,4-triazol-4-ium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -149.904; XAKAVKFLXVMKJT; [M+CH4O+H]+; (1-ethyl-1H-imidazol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -152.713; WXEPBEURAILKFS; [M+H]+; 4-(2-Aminoethyl)-1-methylpiperazin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -154.009; OKQVUMMFRMUJMX; [M+CH4O+H]+; 3-(tert-Butyl)-1H-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -156.123; MIELZMJNYYRADO; [M+CH4O+H]+; 5-methyl-4-propyl-1H-1,2,4-triazol-4-ium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -170.468; ANHJTNKMQWWMDJ; [M+H]+; 2-Amino-1-(4-methyl-piperazin-1-yl)-ethanone
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -186.893; HQXKCSSNQJUVML; [M+H]+; 1-(3-Aminopropyl)tetrahydro-2(1h)-pyrimidinone
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -188.340; PQJWLDHHBMBKDM; [M+H]+; 2-hydroxyimino-N,N-dimethyl-N'-propylethanimidamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -190.271; KIPRVSOTALWIDV; [M+H]+; 3-Amino-1-piperazin-1-yl-propan-1-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -195.122; MPIROZKBCRIFBH; [M+H]+; Piperazine, 1,2,6-trimethyl-4-nitroso-, cis-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -198.158; KNVTVOWFXJOWKI; [M+H]+; 1-(3-Methylbutyl)triazolidin-4-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -220.640; NKNWKZRTEZPNSM; [M+H]+; [(2-ethylbutylidene)amino]urea
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.134; VRZZMRYGHFNKEN; [M+H]+; 2-(4-Methylpiperazin-1-YL)acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.059; HQNOODJDSFSURF; [M+CH4O+H]+; 3-(1H-Imidazol-2-YL)propan-1-amine
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C7H16N3O1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 7.380
MS$FOCUSED_ION: PRECURSOR_M/Z 158.128878
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0a4u-5900000000-6b575f6aa9bc7831406b
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  58.0651339 28.0348 58.065770 1.6705 7.46 0.3212 47 f{C3H8N1}/0.14ppm,p-C4H8N2O1
  70.0650805 24.9819 70.065700 1.4986 6.39 0.0592 44 f{C4H8N1}/-0.64ppm,p-C3H8N2O1
  71.0603268 67.6166 71.060940 1.0273 20.52 -0.0977 49 f{C3H7N2}/-0.67ppm,p-C4H9N1O1
  72.0443435 44.2014 72.044950 1.2215 9.45 0.1981 49 f{C3H6N1O1}/-0.65ppm,p-C4H10N2
  72.0807087 49.0361 72.081315 1.1515 16.67 -0.1572 46 f{C4H10N1}/-0.93ppm,p-C3H6N2O1
  73.0760009 34.5529 73.076600 1.4505 8.91 0.5097 49 f{C3H9N2}/-0.33ppm,p-C4H7N1O1
  85.0760108 23.4700 85.076490 1.9159 5.91 0.1568 40 f{C4H9N2}/-0.16ppm,p-C3H7N1O1
  86.0600533 999.0000 86.060520 0.2905 0.00 0.7220 49 f{C4H8N1O1}/0.15ppm,p-C3H8N2
  87.0916769 27.7184 87.092130 2.0209 8.28 0.0823 46 f{C4H11N2}/0.02ppm,p-C3H5N1O1
  99.0553006 25.0895 99.055630 1.9282 6.34 0.1432 41 f{C4H7N2O1}/0.11ppm,p-C3H9N1
  99.0917109 250.5527 99.092040 0.5147 25.37 0.4437 49 f{C5H11N2}/0.36ppm,p-C2H5N1O1
  102.0913261 59.9756 102.091630 1.1558 14.40 0.3799 49 f{C5H12N1O1}/-0.14ppm,p-C2H4N2
  112.0393348 156.7210 112.039540 0.7944 33.27 -0.0906 49 ?
  113.0710164 59.2576 113.071210 1.0524 11.55 -0.0106 49 f{C5H9N2O1}/0.68ppm,p-C2H7N1
  115.0866596 32.1706 115.086830 1.7639 9.31 0.0670 48 f{C5H11N2O1}/0.61ppm,p-C2H5N1
  129.1024072 36.2825 129.102390 1.9364 8.13 0.2398 49 f{C6H13N2O1}/1.30ppm,p-C1H3N1
  130.0975322 27.2511 130.097500 1.8063 6.46 -0.1448 41 f{C5H12N3O1}/0.34ppm,p-C2H4
  140.0707157 189.4612 140.070620 0.7425 35.94 -0.0697 49 ?
  140.0819257 59.9789 140.081830 1.3920 12.94 0.0587 49 f{C6H10N3O1}/0.62ppm,p-C1H6
  140.1182258 411.9718 140.118130 0.4924 33.55 0.6606 49 f{C7H14N3}/0.01ppm,p-H2O1
  141.0658764 79.4159 141.065780 1.4249 16.25 0.0899 49 ?
  141.1022264 344.3127 141.102130 0.4323 42.38 0.2451 49 f{C7H13N2O1}/-0.09ppm,p-H3N1
  158.0809774 48.9374 158.080870 1.5941 41.39 0.2852 49 ?
  158.0962074 413.7169 158.096100 2.4036 44.52 0.5504 49 ?
  158.1289174 400.7129 158.128810 0.5059 31.96 1.0000 49 f{C7H16N3O1}/0.81ppm,p
  158.1550674 313.1979 158.154960 1.4479 33.73 0.4572 46 ?
PK$NUM_PEAK: 26
PK$PEAK: m/z int. rel.int.
  58.065134 28.03 28
  70.065080 24.98 24
  71.060327 67.62 67
  72.044343 44.20 44
  72.080709 49.04 49
  73.076001 34.55 34
  85.076011 23.47 23
  86.060053 999.00 999
  87.091677 27.72 27
  99.055301 25.09 25
  99.091711 250.55 250
  102.091326 59.98 59
  112.039335 156.72 156
  113.071016 59.26 59
  115.086660 32.17 32
  129.102407 36.28 36
  130.097532 27.25 27
  140.070716 189.46 189
  140.081926 59.98 59
  140.118226 411.97 411
  141.065876 79.42 79
  141.102226 344.31 344
  158.080977 48.94 48
  158.096207 413.72 413
  158.128917 400.71 400
  158.155067 313.20 313
//
